tiprankstipranks
Trending News
More News >
Cautious Hold Rating on Sanofi Due to Safety Concerns and Limited Growth Prospects for Qfitlia
PremiumRatingsCautious Hold Rating on Sanofi Due to Safety Concerns and Limited Growth Prospects for Qfitlia
8d ago
Alnylam announces FDA approval of Qfitlia for treatment of hemophilia A or B
Premium
The Fly
Alnylam announces FDA approval of Qfitlia for treatment of hemophilia A or B
11d ago
FDA approves Sanofi treatment for hemophilia A or B
Premium
The Fly
FDA approves Sanofi treatment for hemophilia A or B
11d ago
Large pharma M&A deals stalling amid volatile policies, Reuters reports
PremiumThe FlyLarge pharma M&A deals stalling amid volatile policies, Reuters reports
14d ago
Sanofi reports tolebrutinib submission accepted for FDA priority review
Premium
The Fly
Sanofi reports tolebrutinib submission accepted for FDA priority review
14d ago
Cantor Fitzgerald calls attention to Alnylam’s Amvuttra’s 30% royalty burden
Premium
The Fly
Cantor Fitzgerald calls attention to Alnylam’s Amvuttra’s 30% royalty burden
14d ago
Trump Trade: Administration explores simplified plans for reciprocal tariffs
PremiumThe FlyTrump Trade: Administration explores simplified plans for reciprocal tariffs
21d ago
Big pharma fears drug price spikes in US-EU tariff spat, Reuters says
Premium
The Fly
Big pharma fears drug price spikes in US-EU tariff spat, Reuters says
22d ago
Sanofi starts annual production of vaccines for 2025-26 flu season
Premium
The Fly
Sanofi starts annual production of vaccines for 2025-26 flu season
25d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100